{"transactions":[{"id":673027,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":18743,"kind":"person","name":"Vandekop Amy O'Leary","position":1,"cik":"0002146984","reported_name":"Vandekop Amy O'Leary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corporate Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-28T16:10:50.000Z","date":"2026-08-27","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on August 27, 2026. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on August 1, 2027 and the remainder vesting in equal monthly installments thereafter, subject to continuous service."}],"balance_after":10000,"derivative":{"exercise_price":4.1,"expiration_date":"2036-08-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-374352","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526374352/ownership.xml","form_type":"4"}}]}